# Filing Detail

Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001140361-23-018462
Filing Date
2023-04-14
Accepted
2023-04-14 16:17:45
Documents
6
Period of Report
2023-06-15

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PRE 14A | ny20007204x1_pre14a.htm | PRE 14A | 622709
2 |  | logo_ardelyxsymbol.jpg | GRAPHIC | 20032
3 |  | ny20007204x1-pc_1.jpg | GRAPHIC | 639019
4 |  | ny20007204x1-pc_2.jpg | GRAPHIC | 407858
5 |  | ny20007204x1_barchart01x1.jpg | GRAPHIC | 171225
6 |  | ny20007204x1_barchart02x1.jpg | GRAPHIC | 175082
| Complete submission text file | 0001140361-23-018462.txt |  | 2568778

Mailing Address 34175 ARDENWOOD BLVD. FREMONT CA 94555
Business Address 34175 ARDENWOOD BLVD. FREMONT CA 94555 510-745-7047
ARDELYX, INC. (Filer) CIK: 0001437402 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36485 | Film No.: 23821394
SIC: 2834 Pharmaceutical Preparations